RG

Rajananda Govindaraj

Director Director DIN 02270321
DIN 02270321 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2009
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajananda Govindaraj

Data last updated:

Rajananda Govindaraj was a Director at Blackbryont Pharmaceuticals Private Limited (2009–2019) and Director at Vernus Healthcare Private Limited (from 2009). The companies operate in Pharma.

DIN 02270321
Primary Designation Director
Industry Pharma
First Appointment 26 May 2009
Oldest Company Age 17 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Sep 20092009₹1.57 Cr (FY 2025)Active
Vernus Healthcare Private Limited U74999TN2009PTC071731
Director26 May 20092009Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Vernus Healthcare Private Limited
Blackbryont Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajananda Govindaraj

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajananda Govindaraj

Rajananda Govindaraj was first appointed on 26 May 2009 as Director at Vernus Healthcare Private Limited.

Rajananda Govindaraj held 2 earlier board appointments: Blackbryont Pharmaceuticals Private Limited (Director, 30 Sep 2009 to 31 Dec 2019); Vernus Healthcare Private Limited (Director, from 26 May 2009).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available